Association of the triglyceride glucose index with myocardial ischemia in patients with minimal to moderate coronary artery disease.
Computed tomography–derived fractional flow reserve
Coronary artery disease
Coronary computed tomography angiography
Myocardial ischemia
Triglyceride glucose index
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
30 10 2024
30 10 2024
Historique:
received:
22
06
2024
accepted:
15
10
2024
medline:
31
10
2024
pubmed:
31
10
2024
entrez:
31
10
2024
Statut:
epublish
Résumé
The triglyceride glucose (TyG) index has been suggested as a reliable substitute to indicate insulin resistance. Several studies have identified the association between the TyG index and cardiovascular disease. However, the association between the TyG index and the incidence of myocardial ischemia in patients with minimal to moderate coronary artery disease (CAD) has not been clearly assessed. We aimed to investigate the association between the TyG index and the incidence of myocardial ischemia in patients with minimal to moderate CAD. A total of 1,697 patients who underwent coronary computed tomography angiography (CTA) examinations and had minimal to moderate CAD were retrospectively included in the study. The TyG index and computed tomography-derived fractional flow reserve (CT-FFR) were used to assess insulin resistance (IR) and myocardial ischemia, respectively. Myocardial ischemia was defined as a CT-FFR value ≤ 0.80. Logistic regression models were used to explore the associations between the TyG index and myocardial ischemia. The incidence of myocardial ischemia was higher in the highest TyG index tertile (T3) group than in the lowest TyG index tertile (T1) group. After adjusting for other variables, the T3 group remained associated with a higher risk of myocardial ischemia than the T1 group did (OR, 1.43; 95% CI, 1.01-2.04; p = 0.047). A 1- standard deviation (SD) increase in the TyG index was correlated with a 19-24% elevated risk of myocardial ischemia when regarding the TyG index was considered as a continuous variable. Subgroup analysis revealed similar effects. A TyG index is associated with a higher risk of myocardial ischemia detected by CT-FFR in patients with minimal to moderate CAD.
Identifiants
pubmed: 39478011
doi: 10.1038/s41598-024-76530-7
pii: 10.1038/s41598-024-76530-7
doi:
Substances chimiques
Triglycerides
0
Blood Glucose
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
26093Subventions
Organisme : Health Commission of Wuhan Municipal Scientific Research Project
ID : WX23B17
Informations de copyright
© 2024. The Author(s).
Références
Cury, R. C. et al. CAD-RADS 2.0 - 2022 coronary artery disease-reporting and data system: An expert consensus document of the society of cardiovascular computed tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI). JACC Cardiovasc. Imaging 15, 1974–2001. https://doi.org/10.1016/j.jcmg.2022.07.002 (2022).
doi: 10.1016/j.jcmg.2022.07.002
pubmed: 36115815
Writing Committee, M. & AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 78, 2218–2261. https://doi.org/10.1016/j.jacc.2021.07.052 (2021).
Arbab-Zadeh, A. & Fuster, V. From detecting the vulnerable plaque to managing the vulnerable patient: JACC state-of-the-art review. J. Am. Coll. Cardiol. 74, 1582–1593. https://doi.org/10.1016/j.jacc.2019.07.062 (2019).
doi: 10.1016/j.jacc.2019.07.062
pubmed: 31537269
Han, D. et al. Prognostic significance of plaque location in non-obstructive coronary artery disease: From the CONFIRM registry. Eur. Heart J. Cardiovasc. Imaging 23, 1240–1247. https://doi.org/10.1093/ehjci/jeab223 (2022).
doi: 10.1093/ehjci/jeab223
pubmed: 34791117
Leipsic, J. et al. Sex-based prognostic implications of nonobstructive coronary artery disease: Results from the international multicenter CONFIRM study. Radiology 273, 393–400. https://doi.org/10.1148/radiol.14140269 (2014).
doi: 10.1148/radiol.14140269
pubmed: 25028784
Emami, H. et al. Nonobstructive coronary artery disease by coronary CT angiography improves risk stratification and allocation of statin therapy. JACC Cardiovasc. Imaging 10, 1031–1038. https://doi.org/10.1016/j.jcmg.2016.10.022 (2017).
doi: 10.1016/j.jcmg.2016.10.022
pubmed: 28330658
pmcid: 6010207
Simental-Mendia, L. E., Rodriguez-Moran, M. & Guerrero-Romero, F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab. Syndr. Relat. Disord. 6, 299–304. https://doi.org/10.1089/met.2008.0034 (2008).
doi: 10.1089/met.2008.0034
pubmed: 19067533
Kim, M. K. et al. Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults. Cardiovasc. Diabetol. 16, 108. https://doi.org/10.1186/s12933-017-0589-4 (2017).
doi: 10.1186/s12933-017-0589-4
pubmed: 28830471
pmcid: 5568209
Sanchez-Inigo, L., Navarro-Gonzalez, D., Fernandez-Montero, A., Pastrana-Delgado, J. & Martinez, J. A. The TyG index may predict the development of cardiovascular events. Eur. J. Clin. Invest. 46, 189–197. https://doi.org/10.1111/eci.12583 (2016).
doi: 10.1111/eci.12583
pubmed: 26683265
Yuan, W., Shao, Y., Zhao, D. & Zhang, B. Correlation analysis of lipid accumulation index, triglyceride-glucose index and H-type hypertension and coronary artery disease. PeerJ. 11, e16069. https://doi.org/10.7717/peerj.16069 (2023).
doi: 10.7717/peerj.16069
pubmed: 37727694
pmcid: 10506588
Pan, W. et al. Triglyceride glucose index is associated with obstructive coronary artery disease in hypertensive patients. Cardiovasc. Diabetol. 22 https://doi.org/10.1186/s12933-023-01739-1 (2023).
Huang, Z. et al. Comparison of prognostic value between CAD-RADS 1.0 and CAD-RADS 2.0 evaluated by convolutional neural networks based CCTA. Heliyon 9, e15988. https://doi.org/10.1016/j.heliyon.2023.e15988 (2023).
doi: 10.1016/j.heliyon.2023.e15988
pubmed: 37215852
pmcid: 10195897
Huang, Z. et al. Clinical evaluation of the Automatic Coronary Artery Disease Reporting and Data System (CAD-RADS) in Coronary computed Tomography Angiography using Convolutional neural networks. Acad. Radiol. 30, 698–706. https://doi.org/10.1016/j.acra.2022.05.015 (2023).
doi: 10.1016/j.acra.2022.05.015
pubmed: 35753936
Dweck, M. R. & Newby, D. E. Non-obstructive coronary artery disease can no longer be ignored. Eur. Heart J. Cardiovasc. Imaging 21, 489–490. https://doi.org/10.1093/ehjci/jeaa022 (2020).
doi: 10.1093/ehjci/jeaa022
pubmed: 32068781
Douglas, P. S. et al. Outcomes of anatomical versus functional testing for coronary artery disease. N. Engl. J. Med. 372, 1291–1300. https://doi.org/10.1056/NEJMoa1415516 (2015).
doi: 10.1056/NEJMoa1415516
pubmed: 25773919
pmcid: 4473773
Investigators, S. H. et al. Coronary CT angiography and 5-Year risk of myocardial infarction. N. Engl. J. Med. 379, 924–933. https://doi.org/10.1056/NEJMoa1805971 (2018).
doi: 10.1056/NEJMoa1805971
Hoffmann, U. et al. Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: Insights from the PROMISE trial (prospective Multicenter Imaging Study for evaluation of chest Pain). Circulation. 135, 2320–2332. https://doi.org/10.1161/CIRCULATIONAHA.116.024360 (2017).
doi: 10.1161/CIRCULATIONAHA.116.024360
pubmed: 28389572
pmcid: 5946057
Min, J. K. et al. Rationale and design of the CONFIRM (COronary CT angiography EvaluatioN for clinical outcomes: An InteRnational Multicenter) Registry. J. Cardiovasc. Comput. Tomogr. 5, 84–92. https://doi.org/10.1016/j.jcct.2011.01.007 (2011).
doi: 10.1016/j.jcct.2011.01.007
pubmed: 21477786
van Rosendael, A. R. et al. Clinical risk factors and atherosclerotic plaque extent to define risk for major events in patients without obstructive coronary artery disease: The long-term coronary computed tomography angiography CONFIRM registry. Eur. Heart J. Cardiovasc. Imaging 21, 479–488. https://doi.org/10.1093/ehjci/jez322 (2020).
doi: 10.1093/ehjci/jez322
pubmed: 32065624
pmcid: 7821703
Maddox, T. M. et al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA 312, 1754–1763. https://doi.org/10.1001/jama.2014.14681 (2014).
doi: 10.1001/jama.2014.14681
pubmed: 25369489
pmcid: 4893304
Hadamitzky, M. et al. Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease. Eur. Heart J. 34, 3277–3285. https://doi.org/10.1093/eurheartj/eht293 (2013).
doi: 10.1093/eurheartj/eht293
pubmed: 24067508
Ihdayhid, A. R. et al. Prognostic value and risk continuum of noninvasive fractional flow reserve derived from coronary CT angiography. Radiology 292, 343–351. https://doi.org/10.1148/radiol.2019182264 (2019).
doi: 10.1148/radiol.2019182264
pubmed: 31184558
Zhao, N. et al. CT-FFR vs a model of combined plaque characteristics for identifying ischemia: Results from CT-FFR CHINA trial. Eur. J. Radiol. 138, 109634. https://doi.org/10.1016/j.ejrad.2021.109634 (2021).
doi: 10.1016/j.ejrad.2021.109634
pubmed: 33721765
Solymoss, B. C. et al. Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease. Coron. Artery Dis. 14, 207–212. https://doi.org/10.1097/01.mca.0000065744.52558.9f (2003).
doi: 10.1097/01.mca.0000065744.52558.9f
pubmed: 12702923
Solymoss, B. C. et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am. J. Cardiol. 93, 159–164. https://doi.org/10.1016/j.amjcard.2003.09.032 (2004).
doi: 10.1016/j.amjcard.2003.09.032
pubmed: 14715340
Norgaard, B. L. et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: The NXT trial (analysis of Coronary Blood Flow using CT angiography: next steps). J. Am. Coll. Cardiol. 63, 1145–1155. https://doi.org/10.1016/j.jacc.2013.11.043 (2014).
doi: 10.1016/j.jacc.2013.11.043
pubmed: 24486266
Yu, B. et al. Triglyceride-glucose index is associated with quantitative flow ratio in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Front. Cardiovasc. Med. 9, 1002030. https://doi.org/10.3389/fcvm.2022.1002030 (2022).
doi: 10.3389/fcvm.2022.1002030
pubmed: 36158820
pmcid: 9493184
Schulman, I. H. & Zhou, M. S. Vascular insulin resistance: A potential link between cardiovascular and metabolic diseases. Curr. Hypertens. Rep. 11, 48–55. https://doi.org/10.1007/s11906-009-0010-0 (2009).
doi: 10.1007/s11906-009-0010-0
pubmed: 19146801
Lee, E. Y. et al. Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes. Lipids Health Dis. 15 https://doi.org/10.1186/s12944-016-0324-2 (2016).
Wang, J., Huang, X., Fu, C., Sheng, Q. & Liu, P. Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome. Cardiovasc. Diabetol. 21, 187. https://doi.org/10.1186/s12933-022-01615-4 (2022).
doi: 10.1186/s12933-022-01615-4
pubmed: 36114495
pmcid: 9482257
Su, J. et al. Triglyceride glucose index for the detection of the severity of coronary artery disease in different glucose metabolic states in patients with coronary heart disease: A RCSCD-TCM study in China. Cardiovasc. Diabetol. 21, 96. https://doi.org/10.1186/s12933-022-01523-7 (2022).
doi: 10.1186/s12933-022-01523-7
pubmed: 35668496
pmcid: 9169264
Zhao, J. et al. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc. Diabetol. 21, 123. https://doi.org/10.1186/s12933-022-01548-y (2022).
doi: 10.1186/s12933-022-01548-y
pubmed: 35778734
pmcid: 9250269
Wang, W. et al. Association between the triglyceride-glucose index and in-hospital major adverse cardiovascular events in patients with acute coronary syndrome: Results from the improving care for Cardiovascular Disease in China (CCC)-Acute Coronary Syndrome project. Cardiovasc. Diabetol. 23, 170. https://doi.org/10.1186/s12933-024-02270-7 (2024).
doi: 10.1186/s12933-024-02270-7
pubmed: 38750553
pmcid: 11097581
Rokicka, D. et al. The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes. Cardiovasc. Diabetol. 23, 147. https://doi.org/10.1186/s12933-024-02240-z (2024).
doi: 10.1186/s12933-024-02240-z
pubmed: 38685054
pmcid: 11059609
Ye, Z. et al. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: Development and external validation of a nomogram model. Cardiovasc. Diabetol. 22, 87. https://doi.org/10.1186/s12933-023-01820-9 (2023).
doi: 10.1186/s12933-023-01820-9
pubmed: 37055777
pmcid: 10103457
Zhao, X. et al. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: An intravascular optical coherence tomography study. Cardiovasc. Diabetol. 20, 131. https://doi.org/10.1186/s12933-021-01321-7 (2021).
doi: 10.1186/s12933-021-01321-7
pubmed: 34183007
pmcid: 8240222
Santulli, G. et al. Prediabetes increases the risk of Frailty in Prefrail older adults with hypertension: Beneficial effects of Metformin. Hypertension 81, 1637–1643. https://doi.org/10.1161/HYPERTENSIONAHA.124.23087 (2024).
doi: 10.1161/HYPERTENSIONAHA.124.23087
pubmed: 38752357